|Audentes Therapeutics Appoints Julie Anne Smith to Board of Directors|
"We are delighted to welcome Julie to our board of directors," stated
Ms. Smith commented, "I am pleased to join the Audentes board of directors at this exciting time in the company's development. 2017 will be an important year as the company plans to enter the clinic and advance its in-house proprietary manufacturing capabilities in pursuit of its vision of bringing transformative therapies to patients living with serious, life threatening rare diseases."
For more information regarding Audentes, please visit www.audentestx.com.
Forward Looking Statements
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/audentes-therapeutics-appoints-julie-anne-smith-to-board-of-directors-300376874.html
Investors + Media